Neuropsychological Assessment of Children and Adolescents With Turner Syndrome (ENEAST)

January 17, 2019 updated by: University Hospital, Angers
Turner syndrome (TS) is a rare chromosomal disorder characterized by partial or complete loss of one of the X chromosomes that affects about one in every 2000 female babies born. These young patients described difficulties making friends, understanding others' emotions and intentions, and controlling their own emotions. Difficulties in these domains could led to social withdrawal, to reduced social skills and could have a significant impact on self esteem and mental health as well as on long-term academic and social functioning in affected individuals. The purpose of this project is to identify functional and dysfunctional cognitive and socio-cognitive abilities in these young patients which could account social difficulties described by some of them and their family. To this end, 35 girls with TS and 35 girls with isolated growth hormone deficiency and normal cerebral MRI will be recruited. Subjects will be 7 to 16 years and 11 months of age. Socio-cognitive and cognitive functions will be assessed with neuropsychological and experimental tasks. Questionnaires completed by patient, parents or teacher, will evaluate social and behavioral functioning.

Study Overview

Detailed Description

Cross-sectional study (2 groups : Turner syndrome, isolated growth hormone deficiency), not randomized, controlled, associating several specialized centers in endocrine diseases.

The pediatric endocrinologist of the participating centers will contact parents of each patient or voluntary child/adolescent in order to inform them of the study.

The visit of inclusion will take place in the participant center during a routine monitoring visit.

The first visit (V1) will take place immediately after the visit of inclusion in order to avoid a specific displacement for the needs for the study. The second visit (V2) will take place in participant's home. Each visit (V1 and V2) will last half-day. The period between V1 and V2 will be three months maximum.

The visits V1 and V2 will be carried out by neuropsychologists of the Laboratoire de Psychologie des Pays de la Loire (LPPL - EA 4638).

Study Type

Observational

Enrollment (Anticipated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

  • 35 patients with Turner syndrome
  • 35 patients with isolated growth hormone deficiency

Description

INCLUSION CRITERIA

Turner syndrome group :

  • girls with diagnosed Turner syndrome.

Isolated GHD group :

  • girls with diagnosed isolated growth hormone deficiency

All participants :

  • age between 7 years to 16 years and 11 months.
  • informed consent signed by the participant and her parents (or her legal representatives)
  • being registered in the national social security system

EXCLUSION CRITERIA :

Turner syndrome group :

  • patients with chronic pathology other than Turner syndrome.
  • karyotype : part of a Y chromosome and r(X) cases.
  • medical treatment other than those usually prescribed in patients with Turner syndrome.

Isolated GHD group :

  • patients with chronic pathology other than isolated growth hormone deficiency.
  • medical treatment other than those usually prescribed in patients with isolated growth hormone deficiency.

All participants :

  • diagnosed intellectual disability (IQ<70) or intellectual giftedness
  • history of acquired brain injury
  • sensory disturbances (auditory or visual) incompatible with the achievement of neuropsychological tasks.
  • insufficient French language proficiency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Turner Syndrome
  • 35 girls with Turner syndrome (except patients with part of a Y chromosome in their karyotype and r(X) cases).
  • age : 7 years -16 years and 11 months.
  • Psychological evaluation of cognition, social cognition and affective cognition
  • Neuropsychological and experimental tasks will assess cognitive and socio-cognitive functions.
  • Questionnaires will assess psychoaffective aspects (depression, anxiety, self-esteem), and social and behavioral functioning.
isolated GHD
  • 35 girls with isolated Growth Hormone Deficiency (GHD).
  • age : 7 years -16 years and 11 months.
  • Psychological evaluation of cognition, social cognition and affective cognition
  • Neuropsychological and experimental tasks will assess cognitive and socio-cognitive functions.
  • Questionnaires will assess psychoaffective aspects (depression, anxiety, self-esteem), and social and behavioral functioning.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wechsler Intelligence Scale for Children (WISC-V)
Time Frame: 3 months
intelligence scale.
3 months
Cognitive theory of mind first order
Time Frame: 3 months
First order theory of mind tasks (Baron-Cohen et al., 1985)
3 months
Cognitive theory of mind second order
Time Frame: 3 months
second-order theory of mind tasks Perner & Wimmer, 1983)
3 months
Cognitive theory of mind advanced
Time Frame: 3 months
advanced theory of mind tasks (Happé, 1994)
3 months
Cognitive theory of mind : humor
Time Frame: 3 months
Humor understanding task
3 months
Affective theory of mind : faux pas
Time Frame: 3 months
Faux pas recognition test (Baron Cohen et al., 1999)
3 months
Affective theory of mind : first order
Time Frame: 3 months
First-order affective theory of mind tasks
3 months
Affective theory of mind : second order
Time Frame: 3 months
Second-order affective theory of mind tasks
3 months
Affective theory of mind : emotional inference
Time Frame: 3 months
Emotional inference for context test
3 months
Emotional valence recognition : valence
Time Frame: 3 months
Emotional valence rating from visual scenes
3 months
Facial emotion recogniton
Time Frame: 3 months
Facial emotion recognition task
3 months
Vocal emotion recognition
Time Frame: 3 months
Emotional prosody recognition task
3 months
Emotional regulation
Time Frame: 3 months
Emotion Regulation Questionnaire for Children and Adolescents (ERQ-CA)
3 months
Alexithymia
Time Frame: 3 months
Questionnaire d'alexithymie chez l'enfant (QAE)
3 months
Empathy
Time Frame: 3 months
Interpersonal Reactivity Index (IRI)
3 months
Oral Language comprehension abilities 1
Time Frame: 3 months
Comprehension of Instructions (NEPSY-II, Korkman et al., 2012)
3 months
Oral Language comprehension abilities 2
Time Frame: 3 months
Verbal comprehension index (from WISC-V)
3 months
Visual and visual-spatial abilities:1
Time Frame: 3 months
Arrows subtest (NEPSY-II - Korkman et al., 2012),
3 months
Visual and visual-spatial abilities:2
Time Frame: 3 months
Picture Puzzles subtest (NEPSY-II - Korkman et al., 2012)
3 months
Visual and visual-spatial abilities:3
Time Frame: 3 months
Benton Facial Recognition Test (Benton et al., 1983)
3 months
Executive abilities-Verbal Working memory 1
Time Frame: 3 months
Verbal information updating task
3 months
Executive abilities-Visuo-Spatial Working memory 2
Time Frame: 3 months
Visuo-spatial information updating task
3 months
Executive abilities-Inhibition 1
Time Frame: 3 months
Stroop test.
3 months
Executive abilities-Inhibition 2
Time Frame: 3 months
Tapping test
3 months
Executive abilities-Inhibition 3
Time Frame: 3 months
non-verbal cancellation task
3 months
Executive abilities-Cognitive Flexibility 1
Time Frame: 3 months
Verbal fluency task (NEPSY-II Korkman et al., 2012)
3 months
Executive abilities-Cognitive Flexibility 2
Time Frame: 3 months
Modified Wisconsin Card Sorting Test for children
3 months
Executive abilities-Cognitive Flexibility 3
Time Frame: 3 months
Trail Making Test
3 months
Executive abilities-Higher-order executive functions 1
Time Frame: 3 months
script generation task
3 months
Executive abilities-Higher-order executive functions 2
Time Frame: 3 months
Rey Complex Figure Test : Copy
3 months
Executive abilities in daily life
Time Frame: 3 months
Behavioral Rating Inventory of Executive Functions
3 months
Self Esteem
Time Frame: 3 months
Rosenberg self-esteem scale (1965).
3 months
Depression inventory
Time Frame: 3 months
Depression: Children's Depression Inventory (Kovacks & Beck, 1977).
3 months
Anxiety inventory
Time Frame: 3 months
Revised Children's Manifest Anxiety Scale (Reynolds & Richmond, 1999).
3 months
Social desirability
Time Frame: 3 months
Children's Social Desirability Scale (Crandall et al., 1965)
3 months
social adjustment 1
Time Frame: 3 months
Conners' Parent Rating Scale-Revised: Short Form (Conners, 1997)
3 months
social adjustment 2
Time Frame: 3 months
Conners' Teacher Rating Scale-Revised: Short Form (Conners, 1997)
3 months
behavioral adjustment
Time Frame: 3 months
Child Behavior Checklist (Achenbach, 1991).
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Régis Coutant, MD PhD, UH Angers

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2019

Primary Completion (Anticipated)

May 1, 2021

Study Completion (Anticipated)

November 1, 2021

Study Registration Dates

First Submitted

October 29, 2018

First Submitted That Met QC Criteria

January 17, 2019

First Posted (Actual)

January 23, 2019

Study Record Updates

Last Update Posted (Actual)

January 23, 2019

Last Update Submitted That Met QC Criteria

January 17, 2019

Last Verified

January 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Isolated Growth Hormone Deficiency

Clinical Trials on psychological evaluation

3
Subscribe